BY ULRICH QUISTGAARD
-
Sandoz sues Amgen in arthritis drug case
Sandoz asserts that Amgen unlawfully got license civil liberties to obstruct more affordable biosimilar rivals.
-
Major pharmaceutical companies hit by higher tariffs in China
A variety of huge pharma firms have United States making websites for medicines marketed in China, which is currently increasing tolls that might restrict the supply of specific me…
-
Novo Nordisk executive’s exit sparks speculation
Minimal interaction from Novo Nordisk has numerous company media electrical outlets hypothesizing on the reasons Camilla Sylvest is tipping down as executive supervisor.
-
Danish industry group warns affiliates of US backlash against DEI
The Confederation of Danish Business advises Danish corporations dealing with the brand new political line within the US to watch out utilizing sure phrases to keep away from US ba…
-
Analysis: Pharmaceutical companies betting on AI and automation to solve operational challenges
The expert company Forrester Research study has actually examined what the pharmaceutical market is buying presently.
-
Leo Pharma factory overruns budget by up to DKK 1.5 bn – production starts in 2026
Leo Pharma’s brand-new totally automated manufacturing facility in Denmark will certainly generate an energetic component for a solitary medicine for which business the busin…
-
Sanofi acquires autoimmune treatment from Dren Bio
The French team reinforces its concentrate on autoimmune conditions by obtaining a myeloid cell engager from Dren Biography. The offer will certainly set you back Sanofi USD 600m u…
-
Roche and Novartis change diversity programs to avoid US sanctions
Roche changes its emphasis to addition and belonging, while Novartis changes its technique however stays fully commited to advertising level playing fields.
-
AstraZeneca to develop new cancer drugs via South Korean deal
AstraZeneca subsidiary MedImmune indicators an unique permit arrangement with South Korean’s Alteogen. The goal is to create subcutaneous therapy options for cancer cells ind…
-
Reactions to EU critical medicines plan are pouring in – regional joint procurement groups delighted
The Danish pharmaceutical market invites the European Payment’s strategies to enhance the continent’s very own supply chains for life-saving medications, yet the strate…